Jan 11, 2021 - Ad war: HUL hits back at Sebamed's campaign, says 'will take suitable action'

From the Editor's Desk

We've Known How to Combat Dementia For Years -- We're Just Not Listening

We're still waiting for that shiny pill to cure us. What if we never find it?

When I started working in my first lab researching Alzheimer's Disease, I was idealistic, determined the field would find a cure for the insidious disease in my lifetime. And I still hope we do. Alzheimer's runs in my family like it does in many families. But my time working in the field has forced me to realize that we already know how to fend off the debilitating effects of dementia. It's just not the answer we were looking for.

For years, I researched in and out of the lab. I took classes about the brain and dementia. I read neuroscience books in my leisure time. I consumed every bit of information the field offered on cognitive decline, dementia, Alzheimer's, and similar diseases. From the vagus nerve to cytokines gone wrong to demyelination, I scoured every potential source of memory loss.

And everything I read, in one way or another, pointed back to the same perpetrator: stress.

Continued here

TradeBriefs: Newsletters for Decision-Makers!

Advertisers of the day

Emeritus: Take your career to a new level with PG Diploma in Digital Business | Accepting Applications

NUS Business School: Stay at the forefront of financial innovations | NUS Business School's FinTech programme

Our advertisers help fund the daily operations of TradeBriefs. We request you to accept our promotional emails.

Want the newsletters, without the promotional mailers?
Get an (ad-free) subscription to TradeBriefs Premium for just $2 per month

"If I can spend $8 on Netflix every month, I can spend $2/month on a TradeBriefs Premium subscription to stay informed & do better at work (and in life)"